182 related articles for article (PubMed ID: 35176433)
1. Ductal metaplasia in pancreas.
Li S; Xie K
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188698. PubMed ID: 35176433
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pancreatic ductal metaplasia.
Jiang T; Wei F; Xie K
J Pathol; 2022 Jun; 257(2):125-139. PubMed ID: 35170758
[TBL] [Abstract][Full Text] [Related]
3. Molecular signaling in pancreatic ductal metaplasia: emerging biomarkers for detection and intervention of early pancreatic cancer.
Li X; He J; Xie K
Cell Oncol (Dordr); 2022 Apr; 45(2):201-225. PubMed ID: 35290607
[TBL] [Abstract][Full Text] [Related]
4. Acinar-to-Ductal Metaplasia (ADM): On the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and Pancreatic Cancer.
Marstrand-Daucé L; Lorenzo D; Chassac A; Nicole P; Couvelard A; Haumaitre C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373094
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL4 accelerates KRAS
Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS
Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic Acinar-to-Ductal Metaplasia and Pancreatic Cancer.
Wang L; Xie D; Wei D
Methods Mol Biol; 2019; 1882():299-308. PubMed ID: 30378064
[TBL] [Abstract][Full Text] [Related]
7. GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant
Shen J; Ha DP; Zhu G; Rangel DF; Kobielak A; Gill PS; Groshen S; Dubeau L; Lee AS
Proc Natl Acad Sci U S A; 2017 May; 114(20):E4020-E4029. PubMed ID: 28461470
[TBL] [Abstract][Full Text] [Related]
8. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.
Storz P
Nat Rev Gastroenterol Hepatol; 2017 May; 14(5):296-304. PubMed ID: 28270694
[TBL] [Abstract][Full Text] [Related]
9. Hes1 Controls Exocrine Cell Plasticity and Restricts Development of Pancreatic Ductal Adenocarcinoma in a Mouse Model.
Hidalgo-Sastre A; Brodylo RL; Lubeseder-Martellato C; Sipos B; Steiger K; Lee M; von Figura G; Grünwald B; Zhong S; Trajkovic-Arsic M; Neff F; Schmid RM; Siveke JT
Am J Pathol; 2016 Nov; 186(11):2934-2944. PubMed ID: 27639167
[TBL] [Abstract][Full Text] [Related]
10. Uncertain Beginnings: Acinar and Ductal Cell Plasticity in the Development of Pancreatic Cancer.
Grimont A; Leach SD; Chandwani R
Cell Mol Gastroenterol Hepatol; 2022; 13(2):369-382. PubMed ID: 34352406
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia.
Shi G; DiRenzo D; Qu C; Barney D; Miley D; Konieczny SF
Oncogene; 2013 Apr; 32(15):1950-8. PubMed ID: 22665051
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of targeting acinar cell reprogramming in pancreatic cancer.
Wong CH; Li YJ; Chen YC
World J Gastroenterol; 2016 Aug; 22(31):7046-57. PubMed ID: 27610015
[TBL] [Abstract][Full Text] [Related]
13. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
[TBL] [Abstract][Full Text] [Related]
14. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.
Shi C; Hong SM; Lim P; Kamiyama H; Khan M; Anders RA; Goggins M; Hruban RH; Eshleman JR
Mol Cancer Res; 2009 Feb; 7(2):230-6. PubMed ID: 19208745
[TBL] [Abstract][Full Text] [Related]
15. Lineage Tracing of Primary Human Pancreatic Acinar and Ductal Cells for Studying Acinar-to-Ductal Metaplasia.
Liu J; Wang P
Methods Mol Biol; 2019; 1882():55-62. PubMed ID: 30378043
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor 1 drives and maintains ductal cell fates in the premalignant pancreas and ductal adenocarcinoma.
Tekin C; Scicluna BP; Lodestijn SC; Shi K; Bijlsma MF; Spek CA
Mol Oncol; 2021 Nov; 15(11):3091-3108. PubMed ID: 33932087
[TBL] [Abstract][Full Text] [Related]
18. Desmoplasia and oncogene driven acinar-to-ductal metaplasia are concurrent events during acinar cell-derived pancreatic cancer initiation in young adult mice.
Johnson BL; d'Alincourt Salazar M; Mackenzie-Dyck S; D'Apuzzo M; Shih HP; Manuel ER; Diamond DJ
PLoS One; 2019; 14(9):e0221810. PubMed ID: 31490946
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated acinar-to-ductal metaplasia within the invasive front of pancreatic cancer contributes to local invasion.
Kibe S; Ohuchida K; Ando Y; Takesue S; Nakayama H; Abe T; Endo S; Koikawa K; Okumura T; Iwamoto C; Shindo K; Moriyama T; Nakata K; Miyasaka Y; Shimamoto M; Ohtsuka T; Mizumoto K; Oda Y; Nakamura M
Cancer Lett; 2019 Mar; 444():70-81. PubMed ID: 30590101
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation.
Nishimon R; Yoshida K; Sanuki F; Nakashima Y; Miyake T; Sato T; Tomiyama Y; Nishina S; Moriya T; Shiotani A; Hino K
Pancreatology; 2023 Nov; 23(7):811-817. PubMed ID: 37659916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]